Class II · ModerateActive recall
Biospectra Tris/Tromethamine
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLot#: TRIS -E04-[redacted-phone]; Exp 2/29/28
Where it was soldCA
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
Failed stability specifications
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | BioSpectra, Inc. |
| NDC | 64173-101-25 |
Show the full FDA record
| Full product label | Biospectra Tris/Tromethamine, USP, GMP, API Grade, Manufactured at 100 Majestic Way, Bangor, PA 18013, NDC 64173-101-25 |
| Recalling firm | BioSpectra, Inc. |
| Distribution | CA |
| Quantity | 200 kg |
| Recall initiated | 2026-07-29 |
| Report date | 2026-10-14 |
| Recall completed | — |
| Recall number | D-0012-2027 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Bangor PA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.